World's Best Scientists 2026 revealed!
Ayalew Tefferi

Ayalew Tefferi

Award Badge
Best Scientists
2025

D-Index & Metrics

Best Scientists

D-Index
174
Citations
121856
World Ranking
745
National Ranking
459

Medicine

D-Index
175
Citations
126647
World Ranking
430
National Ranking
259

Research.com Recognitions

  • 2025 - Research.com Best Scientists Award

Overview

Ayalew Tefferi is affiliated with Mayo Clinic in the United States and has a significant research presence spanning multiple subfields of medicine, with a primary focus on hematology. Their work also covers genetics, molecular biology, rheumatology, and oncology, contributing broadly to medical science.

Their research topics include:

  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Acute Myeloid Leukemia Research
  • Chronic Myeloid Leukemia Treatments
  • Eosinophilic Disorders and Syndromes
  • Kruppel-like factors research
  • Hemoglobinopathies and Related Disorders
  • Chronic Lymphocytic Leukemia Research

Tefferi's publication record spans several influential journals, with the most frequent venues being:

  • American Journal of Hematology
  • Blood
  • Blood Cancer Journal
  • Haematologica
  • British Journal of Haematology

Notable recent papers include:

  • International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data (2022, Blood)
  • Primary myelofibrosis: 2021 update on diagnosis, risk-stratification and management (2020, American Journal of Hematology)
  • Primary myelofibrosis: 2023 update on diagnosis, risk-stratification, and management (2023, American Journal of Hematology)
  • Mutation-enhanced international prognostic systems for essential thrombocythaemia and polycythaemia vera (2020, British Journal of Haematology)
  • Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia (2022, Blood)

The scientist collaborates frequently with other researchers, with notable coauthors including:

  • Naseema Gangat
  • Mrinal M. Patnaik
  • Animesh Pardanani
  • Aref Al-Kali
  • Mark R. Litzow

Their work largely contributes to understanding diagnostic and therapeutic strategies in myeloid neoplasms and leukemias, integrating clinical, genomic, and morphologic data. Tefferi's research output encompasses a substantial number of publications, reflecting sustained contributions to advancing hematological science.

Best Publications

  • The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

    James W. Vardiman;Jüergen Thiele;Daniel A. Arber;Richard D. Brunning

  • Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.

    Ross L. Levine;Ross L. Levine;Martha Wadleigh;Jan Cools;Benjamin L. Ebert;Benjamin L. Ebert

  • A Tyrosine Kinase Created by Fusion of the PDGFRA and FIP1L1 Genes as a Therapeutic Target of Imatinib in Idiopathic Hypereosinophilic Syndrome

    Jan Cools;Jan Cools;Daniel J. DeAngelo;Jason Gotlib;Elizabeth H. Stover

  • Safety and Efficacy of INCB018424, a JAK1 and JAK2 Inhibitor, in Myelofibrosis

    Srdan Verstovsek;Hagop Kantarjian;Ruben A. Mesa;Animesh D. Pardanani

  • New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment.

    Francisco Cervantes;Brigitte Dupriez;Arturo Pereira;Francesco Passamonti

  • Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms.

    A Tefferi;J W Vardiman

  • MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients

    Animesh D. Pardanani;Ross L. Levine;Terra Lasho;Yana Pikman

  • DIPSS Plus: A Refined Dynamic International Prognostic Scoring System for Primary Myelofibrosis That Incorporates Prognostic Information From Karyotype, Platelet Count, and Transfusion Status

    Naseema Gangat;Domenica Caramazza;Rakhee Vaidya;Geeta George

  • Myelofibrosis with myeloid metaplasia.

    Ayalew Tefferi

  • Philadelphia-Negative Classical Myeloproliferative Neoplasms: Critical Concepts and Management Recommendations From European LeukemiaNet

    Tiziano Barbui;Giovanni Barosi;Gunnar Birgegard;Francisco Cervantes

  • Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel.

    Ayalew Tefferi;Juergen Thiele;Attilio Orazi;Hans Michael Kvasnicka

  • Mutations and prognosis in primary myelofibrosis

    Alessandro Maria Vannucchi;Tl Lasho;Paola Guglielmelli;Flavia Biamonte

  • A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment)

    Francesco Passamonti;Francisco Cervantes;Alessandro Maria Vannucchi;Enrica Morra

  • Survival and prognosis among 1545 patients with contemporary polycythemia vera: An international study

    A Tefferi;E Rumi;G Finazzi;H Gisslinger

  • The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts

    Camille Abboud;Ellin Berman;Adam Cohen

  • Long-term survival and blast transformation in molecularly-annotated essential thrombocythemia, polycythemia vera and myelofibrosis

    Ayalew Tefferi;Paola Guglielmelli;Dirk R. Larson;Christy Finke

  • Role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders

    Ross L. Levine;Animesh Pardanani;Ayalew Tefferi;D. Gary Gilliland

  • Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2 , MPL , TET2 , ASXL1 , CBL , IDH and IKZF1

    A Tefferi

  • Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis)

    Tiziano Barbui;Guido Finazzi;Alessandra Carobbio;Juergen Thiele

  • CALR vs JAK2 vs MPL -mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons

    A Tefferi;T L Lasho;C M Finke;R A Knudson

Frequent Co-Authors

Terra L. Lasho
Terra L. Lasho Mayo Clinic
Curtis A. Hanson
Curtis A. Hanson Mayo Clinic
Ruben A. Mesa
Ruben A. Mesa The University of Texas Health Science Center at San Antonio
Alessandro M. Vannucchi
Alessandro M. Vannucchi University of Florence
Mark R. Litzow
Mark R. Litzow Mayo Clinic
Tiziano Barbui
Tiziano Barbui FROM-Fondazione per la Ricerca Ospedale di Bergamo
David P. Steensma
David P. Steensma Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine doesn’t always mean becoming a doctor. The healthcare field offers many rewarding pathways that can start online or at schools with more flexible admission requirements. If you’re interested in advanced nursing roles but don’t yet have a nursing license, there are online direct entry msn programs for non-nurses that allow career changers to earn a Master of Science in Nursing quickly, setting a solid foundation for roles in clinical or leadership settings.

For those looking for accessible programs, consider nursing schools with high acceptance rates. These schools make entering the nursing profession more feasible, especially if you’re concerned about competitive admissions.

If direct patient care isn’t your ideal path, you could explore online medical coding classes with financial aid. This route opens doors to administrative healthcare positions and often offers flexible study options.

Prospective Licensed Practical Nurses can also benefit from finding an lpn program without teas test, removing barriers that might keep you from starting your nursing journey.

Best Scientists Citing Ayalew Tefferi

Trending Scientists

Recently Published Articles